Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 2 minute read Pharma Industry News Novartis’ Kisqali plus endocrine therapy shows significant PFS benefits in advanced breast cancer trials Swiss pharmaceutical giant Novartis has announced that its breast cancer drug, Kisqali (ribociclib), when used in combination with… bypharmanewsdailyDecember 9, 2018
